Overview
Judith L. Toffenetti applied the recent rejection of a patent for a cloned sheep to the patenting process for 3-D bioprinting, saying that the court rejected the clone patent because “there is nothing in the specification that indicates that the cloned animal is any different from the naturally occurring animal. The claims indicate it’s an identical copy, and therefore, the court found that it is a product of nature.” For that reason Dr. Toffenetti urged those drafting 3-D bioprinting patents “to be sure to put in the differences between the naturally occurring and the invented.” Read the full article